CD19-Synthetic T Cell Antigen Receptor(STAR)-T in B-cell Malignancies Patients

Clinical trial NCT03953599 · COMPLETED

Trial details

NCT number: NCT03953599
Sponsor: Hebei Yanda Ludaopei Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

B Cell Malignancy

Start date: 2019-07-01
Primary completion: 2021-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.